Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

California HIV testing initiatives “could serve as national models”

This article was originally published in Clinica

Executive Summary

The San Francisco AIDS Foundation has said it will be investing $400,000 on two projects aimed at the early detection of and subsequent therapy for acute HIV.

You may also be interested in...



US: The sun shines in on industry-doctor relationships

The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean

Global regulators and industry execs to gather in US and Germany to talk device regulation

Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.

Global regulators/industry to gather in US and Germany to talk device regulation

Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.

Topics

UsernamePublicRestriction

Register

MT042432

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel